SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jenna who wrote (102396)6/15/2000 1:04:00 PM
From: lizard lick  Read Replies (1) of 120523
 
Buying CVM today for a hold,,

DJN: DJ Cel-Sci/Cancer Institute -2: Seeks To Develop HIV Vaccine
(Dow Jones 06/15 12:45:10)

VIENNA, Va. (Dow Jones)--Cel-Sci Corp. (CVM) and the National Cancer
Institute agreed to jointly test the institute's HIV peptide epitopes and
the company's L.E.A.P.S. platform technology for peptide delivery.
In a press release Thursday, Cel-Sci said the collaboration seeks to develop
an improved HIV vaccine for use in HIV treatment and prevention.
The collaboration will evaluate the types of immune responses elicited by
L.E.A.P.S. constructs using HIV peptides developed in specialized animal
testing models available at the Institute.
The L.E.A.P.S. technology allows for the preparation of designer vaccines
that can selectively target particular immune cells and elicit cellular or
humoral (antibody) responses.
Cel-Sci's American Stock Exchange-listed shares recently traded at 3 1/4, up
3/16 or 6.1%, on composite volume of 32,800 shares, compared with average
daily volume of 174,101 shares.
-Dorothea Degen; Dow Jones Newswires; 201-938-5400

(END) DOW JONES NEWS 06-15-00
12:45 PM
S.DJ CVM I/BTC I/MTC N/DJN N/DJWI M/NND M/TEC P/DPH R/NME R/US R/USS R/VA
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext